Dr. Angela Ruban

Nursing - General Program
חוג לסיעוד-תכנית כללית סגל אקדמי בכיר
Dr. Angela Ruban
Phone: 03-6406259
Fax: 03-6409496
Office: Health Professions

Publications

Avissar, S, Matuzany-Ruban, A, Tzukert, K, Schreiber, G.: b-arrestin-1 levels are reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain. Am. J. Psychiatry Vol. 161; pp.2066-72, 2004. 

 

Matuzany-Ruban, A, Avissar, S, Schreiber, G.: Dynamics of beta-arrestin1 protein and mRNA levels elevation by antidepressant in mononuclear leukocytes of patients with depression. Affective dis. Vol. 88; pp. 307-312, 2005. 

 

Matuzany-Ruban, A, Schreiber, G, Farkash, P, Avissar, S.: Phosducin-like protein levels in leukocytes of patients with major depression and in rat cortex: the effect of chronic treatment with antidepressants. Psychiatry Res. Vol. 141(3); pp. 287-94, 2006. 

 

Zlotnik, A, Gurevich, B, Cherniavsky, E, Tkachov, SMatuzani-Ruban, A, Leon, A., Shapira, Y. and Teichberg, V.: The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injure. Neurochem Res. Vol. 33(6); pp. 1044-50, 2008.

 

Marosi, M, Fuzik, J, Nagy, D, Rákos, G, Kis, Z, Vécsei, L, Toldi, J, Ruban-Matuzani, A, Teichberg, VI, Farkas, T.: Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion. Eur J Pharmacol. Vol. 604(1-3); pp. 51-7, 2009

 

Matuzany-Ruban, A, Golan, M, Miroshnik, N, Schreiber, G, Avissar, S.: Normalization of GRK2 protein and mRNA measures in patients with depression predict response to antidepressants. Int J Neuropsychopharmacol. Vol. 29; pp. 83-91, 2009.

 

Ruban, A, Berkutzki T, Cooper I, Mohar B. and Teichberg, Vivian, I.: Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted glioma. Invest New Drugs. Vol. 30(6); pp. 2226-35, 2012.

 

Pérez-Mato, M, Ramos-Cabrer, P, Sobrino T, Blanco, M, Ruban, A, Mirelman, D, Menendez, P, Castillo, J, Campos, F.: Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia. Cell Death Dis. Vol. 9; 5:e992, 2014.

 

Ruban, A, Mohar, B, Jona, G, Teichberg, VI.: Blood glutamate scavenging as a novel neuroprotective treatment for paraoxon intoxication. J Cereb Blood Flow Metab. Vol. 34(2); pp. 1-7, 2014.

 

Schwartz-Arad, D, Ofec, R, Eliyahu, G, Ruban, A, Sterer, N.: Long Term Follow-Up of Dental Implants Placed in Autologous Onlay Bone Graft.  Clin Implant Dent Rel Res. doi: 10.1111/cid.12288; 2014. 

 

Ruban, A, Biton, I, Markovich, A. and Mirelman, D.: MRS of Brain Metabolite Levels Demonstrates the Ability of Scavenging of Excess Brain Glutamate to Protect against Nerve Agent Induced Seizures. Int. J. Mol. Sci. Vol. 16 (2); pp. 3226-36, 2015. 

 

Ruban, A, Cohen-Kashi Malina K, Cooper I, Graubardt N, Babakin L, Jona G, and Teichberg V. Combined treatment of an ALS rat model with recombinant GOT1 and Oxaloacetic acid: a novel neuroprotective treatment. Neurodegen Dis. 2015. 

 

Schwartz-Arad, D, Ofec, R, Eliyahu, G, Sterer, N, Ruban, A. Onlay Bone Graft augmentation for the Treatment of Maxillary Atrophy: Implants long term follow-up (up to 131 months). J Cosmetic Dentistry Vol. 31(3); pp 76-93, 2015. 

 

Goldshmit A, Jona G, Schmuklerd E, Solomond S, Pinkas-Kramarskid R and Ruban A. Blood Glutamate Scavenger as a novel neuroprotective treatment in spinal cord injury. J Neurotrauma Mar 1. doi: 10.1089/neu.2017.5524, 2018.

 

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>